<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">60481</article-id><article-id pub-id-type="doi">10.7554/eLife.60481</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Identification of PARP-7 substrates reveals a role for MARylation in microtubule control in ovarian cancer cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-196639"><name><surname>Palavalli Parsons</surname><given-names>Lavanya H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-196641"><name><surname>Challa</surname><given-names>Sridevi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-196640"><name><surname>Gibson</surname><given-names>Bryan A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-196642"><name><surname>Nandu</surname><given-names>Tulip</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-196643"><name><surname>Stokes</surname><given-names>MiKayla S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2144-4343</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-196644"><name><surname>Huang</surname><given-names>Dan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-196645"><name><surname>Lea</surname><given-names>Jayanthi S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1420"><name><surname>Kraus</surname><given-names>W Lee</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8786-2986</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Ob/Gyn</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Signalling and Gene Regulation Laboratory, Cecil H. and Ida Green Center for Reproductive Biology Sciences</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-195046"><name><surname>Leung</surname><given-names>Anthony K. L.</given-names></name><role>Reviewing editor</role><aff/></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>LEE.KRAUS@utsouthwestern.edu</email> (WK);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>01</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e60481</elocation-id><history><date date-type="received"><day>27</day><month>06</month><year>2020</year></date><date date-type="accepted"><day>20</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Palavalli Parsons et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Palavalli Parsons et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-60481-v1.pdf"/><abstract><p>PARP-7 (TiPARP) is a mono(ADP-ribosyl) transferase whose proteins substrates and biological activities are poorly understood. We observed that <italic>PARP7</italic> mRNA levels are lower in ovarian cancer patient samples compared to non-cancerous tissue, but PARP-7 protein nonetheless contributes to several cancer-related biological endpoints in ovarian cancer cells (e.g., growth, migration). Global gene expression analyses in ovarian cancer cells subjected to PARP-7 depletion indicate biological roles for PARP-7 in cell-cell adhesion and gene regulation. To identify the MARylated substrates of PARP-7 in ovarian cancer cells, we developed an NAD<sup>+</sup> analog-sensitive approach, which we coupled with mass spectrometry to identify the PARP-7 ADP-ribosylated proteome in ovarian cancer cells, including cell-cell adhesion and cytoskeletal proteins. Specifically, we found that PARP-7 MARylates α-tubulin to promote microtubule instability, which may regulate ovarian cancer cell growth and motility. In sum, we identified an extensive PARP-7 ADP-ribosylated proteome with important roles in cancer-related cellular phenotypes.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01 DK069710</award-id><principal-award-recipient><name><surname>Kraus</surname><given-names>W Lee</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Bryan A Gibson, Holds the patents on the anti-MAR binding reagent (United States Patent No. 9,599,606) and the asPARP technology (United States Patent No. 9,926,340) described herein.  UT Southwestern Medical Center has licensed the anti-MAR binding reagent to EMD Millipore, which markets it for research purposes.  BIOLOG Life Science Institute, a coholder of United States Patent No. 9,926,340, sells the NAD+ analog 8-Bu(3-yne)T-NAD+..</p></fn><fn fn-type="conflict" id="conf3"><p>W Lee Kraus, Is a founder consultant for Ribon Therapeutics, Inc.  Holds the patents on the anti-MAR binding reagent (United States Patent No. 9,599,606) and the asPARP technology (United States Patent No. 9,926,340) described herein.  UT Southwestern Medical Center has licensed the anti-MAR binding reagent to EMD Millipore, which markets it for research purposes.  BIOLOG Life Science Institute, a coholder of United States Patent No. 9,926,340, sells the NAD+ analog 8-Bu(3-yne)T-NAD+..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The RNA-seq sets generated for this study can be accessed from the NCBI's Gene Expression Omnibus (GEO) repository (http://www.ncbi.nlm.nih.gov/geo/) using the superseries accession number GSE153395.  The new mass spec data sets generated for these studies are available as supplemental data provided with this manuscript.  They can also be accessed from the Spectrometry Interactive Virtual Environment (MassIVE) repository (https://massive.ucsd.edu/ProteoSAFe/static/massive.jsp) using accession number MSV000086611.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Palavalli Parsons LH</collab><collab>Gibson BA</collab><collab>Challa S</collab><collab>Nandu T.</collab><collab>Stokes MS</collab><collab>Huang D</collab><collab>Lea JS</collab><collab>Kraus WL</collab></person-group><year iso-8601-date="2020">2020</year><source>Substrate Identification Using a Chemical Genetics Approach Reveals a Role for PARP-7-Mediated MARylation in Controlling Microtubule Stability in Ovarian Cancer Cells</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE153395">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE153395</ext-link><comment>NCBI Gene Expression Omnibus, GSE153395</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Palavalli Parsons LH</collab><collab>Gibson BA</collab><collab>Challa S</collab><collab>Nandu T.</collab><collab>Stokes MS</collab><collab>Huang D</collab><collab>Lea JS</collab><collab>Kraus WL</collab></person-group><year iso-8601-date="2020">2020</year><source>Substrate Identification Using a Chemical Genetics Approach Reveals a Role for PARP-7-Mediated MARylation in Controlling Microtubule Stability in Ovarian Cancer Cells</source><ext-link ext-link-type="uri" xlink:href="ftp://MSV000086611@massive.ucsd.edu Username for FTP access: MSV000086611">ftp://MSV000086611@massive.ucsd.edu Username for FTP access: MSV000086611</ext-link><comment>MassIVE, MSV000086611</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>The GTEx Consortium</collab></person-group><year iso-8601-date="2020">2020</year><source>GTEx Analysis Release V8</source><ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/">https://gtexportal.org/home/</ext-link><comment>dbGaP, Accession phs000424.v8.p2</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Zefang Tang</collab><collab>Tianxiang Chen</collab><collab>Chenwei Li and Boxi Kang</collab></person-group><year iso-8601-date="2020">2020</year><source>GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis</source><ext-link ext-link-type="uri" xlink:href="http://gepia2.cancer-pku.cn/#analysis">http://gepia2.cancer-pku.cn/#analysis</ext-link><comment>Nucleic Acids Res, 10.1093/nar/gkz430.</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-60481-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>